an overview of novel treatment approaches in tp53-mutated aml
Published 3 weeks ago • 98 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
5:16
an analysis of tp53 mutation in aml and hr-mds
-
1:26
updates in the treatment landscape of p53-mutated aml/mds
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
1:40
outcomes of allohsct in tp53-mutated aml and mds
-
2:04
sleep quality and weight loss in stem cell transplant recipients
-
9:25
improving mds management: new targets, drug combinations, and personalized and cellular therapies
-
4:31
itp - low platelet counts treatment in ayurveda - real testimonial
-
1:20
impact of tp53 mutations on outcomes in myelofibrosis
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:03
significance of p53 mutations in aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
1:36
innovations in mds and aml treatment
-
2:50
magrolimab in tp53 mutated aml and mds
-
4:14
future therapies for aml: bispecifics and small molecule inhibitors
-
1:46
the impact of novel therapies on cardiovascular treatment-related adverse events
-
2:38
how to treat difficult forms of mds
-
1:50
novel treatment regimens under investigation for richter's transformation